Cryo vs RF Efficacy Model (AF Ablation) Calculator

Cryo vs RF Efficacy Model: Explanation and Clinical Context This calculator estimates the probability of remaining free from atrial tachyarrhythmia about 12 months after a single catheter ablation procedure and compares cryoballoon ablation (Cryo) with radiofrequency ablation (RF). It uses the validated APPLE score (Age > 65 years, persistent AF, eGFR < 60 ml/min/1.73 m2, left atrial diameter ≥ 43 mm, and LVEF < 50%) to predict baseline recurrence risk. Recurrence rates are based on published APPLE cohorts: 19% (score 0), 28% (1), 39% (2), and 52% (≥3).

Since large randomized trials and meta-analyses demonstrate noninferior and equivalent efficacy between Cryo and RF for first-line PVI, both modalities are modeled as having similar outcomes. Normal/Expected Values Typical single-procedure arrhythmia-free rates at 1 year are 65–75% for paroxysmal AF, and lower for persistent AF. Clinical Significance The APPLE score allows quick pre-procedural estimation of recurrence risk, applicable to both Cryo and RF.

It helps guide patient counseling, follow-up planning, and strategy optimization. Clinical Interpretation Summary Use the APPLE-based recurrence probability to tailor expectations and management. Expect similar efficacy for Cryo and RF; modality choice should instead consider anatomy, operator experience, and safety nuances.